Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN102690252B details a novel Stiripentol synthesis route converting synthesis by-products into high-value epilepsy intermediates, offering significant cost and supply chain advantages.
Patent CN1187346C reveals a novel route for benzisothiazole derivatives, offering significant cost reduction in fine chemical manufacturing and enhanced supply chain reliability.
Novel five-step route for milabelin intermediate ensures high purity and yield. Reliable pharmaceutical intermediates supplier offering cost reduction in API manufacturing.
Discover a novel oxidation method for Losartan metabolite EXP-3174 offering high purity and yield. Ideal for cost reduction in API manufacturing and scalable supply.
Advanced water-crystallization technology for Transbroncho alkali refinement. Achieve >99% purity for Ambroxol HCl synthesis with reduced costs and simplified supply chains.
Novel Oxone-based route for CAS 1417287-40-1 eliminates ruthenium catalysts ensuring scalable high-purity pharmaceutical intermediate supply chains.
Patent CN105061393B reveals a novel route for (S)-(-)-3-methylamino-1-(2-thienyl)-1-propanol, offering >99% purity and >80% yield for scalable duloxetine production.
Novel patent CN114671782A details a scalable synthesis of chiral halohydrin amines from L-phenylalanine, offering high purity and cost-effective manufacturing for antiviral intermediates.
Novel two-step catalytic method for high-purity 1-tert-butyl-L-glutamic acid. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Novel imidazo pyridine derivatives offer safer gout treatment options with scalable synthesis routes for global pharmaceutical supply chains and reduced hepatotoxicity risks.
Novel 4-step bunazosin synthesis patent CN120665049A offers higher yield and environmental benefits. Reliable pharmaceutical intermediates supplier for scale-up.
Patent CN108610340A details a high-purity triazolopyridine synthesis route. Discover cost reduction in API manufacturing and scalable supply chain solutions for oncology intermediates.
Patent CN106146543A details efficient Rh-catalyzed synthesis of chiral alpha-amino tertiary borates, offering cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN103073456B details a high-purity stereoselective synthesis for rivastigmine intermediates, offering significant cost reduction in API manufacturing and scalable production.
Novel resolution method for argatroban starting material improves purity and yield. Offers supply chain stability and cost efficiency for pharmaceutical manufacturing.
Advanced patent CN106146543A enables efficient synthesis of chiral alpha-amino tertiary borates. High enantioselectivity and scalable process for pharmaceutical intermediates.
Novel synthesis route for Ciprofibrate improves yield and purity. Reduces waste and energy. Reliable API intermediate supplier for pharma manufacturing.
Patent CN109438432B details a green emtricitabine synthesis using L-menthol. Offers cost reduction in antiviral API manufacturing and high-purity intermediates.
Patent CN112745327A reveals a safer, high-yield route for NT02a. Avoids explosive diazotization, ensuring reliable supply and cost reduction for API manufacturing.
Patent CN112574092B reveals a green aqueous method for high-purity indole derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.